Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Howe

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of Virology|September 25, 2009
Structure-function analysis of human immunodeficiency virus type 1 gp120 amino acid mutations associated with resistance to the CCR5 coreceptor antagonist vicrivirocRobert A Ogert, Lei Ba, Yan Hou, et al.
Open Forum Infectious Diseases|March 4, 2015
Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants on the Efficacy of Boceprevir Combined With Peginterferon/RibavirinJohn A Howe, Jianmin Long, Stuart Black, et al.
Marine Pollution Bulletin|November 15, 2016
Ecosystem uptake and transfer of Sellafield-derived radiocarbon (<sup>14</sup>C). Part 1. The Irish SeaGraham K P Muir, Kieran M Tierney, Gordon T Cook, et al.
Marine Pollution Bulletin|December 1, 2016
Ecosystem uptake and transfer of Sellafield-derived radiocarbon (<sup>14</sup>C) part 2: The West of ScotlandKieran M Tierney, Graham K P Muir, Gordon T Cook, et al.
Virology|February 23, 2010
Clinical resistance to vicriviroc through adaptive V3 loop mutations in HIV-1 subtype D gp120 that alter interactions with the N-terminus and ECL2 of CCR5Robert A Ogert, Yan Hou, Lei Ba, et al.
Journal of Environmental Radioactivity|February 13, 2018
Deposition of artificial radionuclides in sediments of Loch Etive, ScotlandHamza Al-Qasmi, Gareth T W Law, L Keith Fifield, et al.
Virology|October 26, 2005
Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectorsJohn A Howe, Peter Pelka, Doug Antelman, et al.
The Journal of Infection|October 25, 2024
Evaluation of a non-nucleoside inhibitor of the RSV RNA-dependent RNA polymerase in translatable animals modelsMichael P Citron, Xiaowei Zang, Andrew Leithead, et al.
Antimicrobial Agents and Chemotherapy|December 4, 2023
Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistanceJulie M Strizki, John M Gaspar, John A Howe, et al.
Cancer Research|July 23, 2003
Pharmacologic indicators of antitumor efficacy for oncolytic virotherapyG William Demers, Duane E Johnson, Van Tsai, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Virology|September 25, 2009
Structure-function analysis of human immunodeficiency virus type 1 gp120 amino acid mutations associated with resistance to the CCR5 coreceptor antagonist vicrivirocRobert A Ogert, Lei Ba, Yan Hou, et al.
Open Forum Infectious Diseases|March 4, 2015
Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants on the Efficacy of Boceprevir Combined With Peginterferon/RibavirinJohn A Howe, Jianmin Long, Stuart Black, et al.
Marine Pollution Bulletin|November 15, 2016
Ecosystem uptake and transfer of Sellafield-derived radiocarbon (<sup>14</sup>C). Part 1. The Irish SeaGraham K P Muir, Kieran M Tierney, Gordon T Cook, et al.
Marine Pollution Bulletin|December 1, 2016
Ecosystem uptake and transfer of Sellafield-derived radiocarbon (<sup>14</sup>C) part 2: The West of ScotlandKieran M Tierney, Graham K P Muir, Gordon T Cook, et al.
Virology|February 23, 2010
Clinical resistance to vicriviroc through adaptive V3 loop mutations in HIV-1 subtype D gp120 that alter interactions with the N-terminus and ECL2 of CCR5Robert A Ogert, Yan Hou, Lei Ba, et al.
Journal of Environmental Radioactivity|February 13, 2018
Deposition of artificial radionuclides in sediments of Loch Etive, ScotlandHamza Al-Qasmi, Gareth T W Law, L Keith Fifield, et al.
Virology|October 26, 2005
Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectorsJohn A Howe, Peter Pelka, Doug Antelman, et al.
The Journal of Infection|October 25, 2024
Evaluation of a non-nucleoside inhibitor of the RSV RNA-dependent RNA polymerase in translatable animals modelsMichael P Citron, Xiaowei Zang, Andrew Leithead, et al.
Antimicrobial Agents and Chemotherapy|December 4, 2023
Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistanceJulie M Strizki, John M Gaspar, John A Howe, et al.
Cancer Research|July 23, 2003
Pharmacologic indicators of antitumor efficacy for oncolytic virotherapyG William Demers, Duane E Johnson, Van Tsai, et al.
Pageof 5